Risks of Aromatase Inhibitor-Related Cardiotoxicity in Patients with Breast Cancer in Asia.
Wei-Ting ChangPo-Wei ChenHui-Wen LinYu-Hsuan KuoSheng-Hsiang LinYi-Heng LiPublished in: Cancers (2022)
In this Asian cohort, we found that among patients of old age or with advanced cancer stage, the use of SERMs was associated with a higher risk of cardiovascular events than the use of AIs.